Fit for purpose high‐throughput absolute quantitation of chimeric aducanumab in mouse cortex and plasma
Emma H Doud, Kathryn A Haynes, Diogo Francisco Silva Santos, Amber L Mosley, Sara K Quinney, Stacey J Sukoff Rizzo, Paul R Territo · 2025
Read Fit for purpose high‐throughput absolute quantitation of chimeric aducanumab in mouse cortex and plasma by Emma H Doud, Kathryn A Haynes, Diogo Francisco Silva Santos, Amber L Mosley, Sara K Quinney, Stacey J Sukoff Rizzo, Paul R Territo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709830.txt.
Description
Seven authors build a fast mass spec count for a brain drug in mouse tissue in 2025. Glue-based tests fail on tight-bind drugs, with murk and bent curves. Their path picks drug-only bits, spikes in marked twin bits, and reads counts by mass steps.
The count stays straight across a huge span, with repeat spread of three to ten percent. A catch step with a bind protein cut the floor a hundred-fold. One plate of 96 samples runs in two to three days, and the flow is shared for like drug work.
Catalog record
| CREATOR | Emma H Doud, Kathryn A Haynes, Diogo Francisco Silva Santos, Amber L Mosley, Sara K Quinney, Stacey J Sukoff Rizzo, Paul R Territo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |